Brastib

Brastib is an oral medication containing Lapatinib, used to treat certain types of cancer. This pharmaceutical is manufactured by Stada Arzneimittel AG and is intended for oral use.

Brastib, containing the active ingredient Lapatinib, is primarily used in the treatment of specific types of cancer. It is often prescribed for patients who have certain forms of breast cancer that have spread to other parts of the body. Lapatinib works by targeting and inhibiting the growth of cancer cells, helping to slow the progression of the disease. Patients may wonder, 'What is Brastib used for?' and the answer lies in its role as a targeted therapy for advanced breast cancer.

Common effects of Brastib may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some patients may also experience fatigue, rash, or changes in liver function. These effects can vary from person to person and may not affect everyone who takes the medication. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Brastib should be handled with care and stored according to the manufacturer's guidelines. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant or breastfeeding women should discuss the use of Brastib with their healthcare provider before starting treatment.

Brastib may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. This can affect the effectiveness of Brastib or other medications. Patients should avoid consuming grapefruit or grapefruit juice, as it can interfere with the metabolism of Lapatinib. It is also important to discuss the use of herbal supplements and over-the-counter medications with a healthcare provider to ensure safety.